- Home
- EXLS vs BIO Comparison
EXLS vs BIO Comparison
Compare EXLS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXLS
- BIO
- Stock Information
- Founded
- EXLS 1999
- BIO 1952
- Country
- EXLS United States
- BIO United States
- Employees
- EXLS N/A
- BIO N/A
- Industry
- EXLS Business Services
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- EXLS Consumer Discretionary
- BIO Industrials
- Exchange
- EXLS Nasdaq
- BIO Nasdaq
- Market Cap
- EXLS 7.0B
- BIO 7.7B
- IPO Year
- EXLS 2006
- BIO N/A
- Fundamental
- Price
- EXLS $43.07
- BIO $305.80
- Analyst Decision
- EXLS Strong Buy
- BIO Strong Buy
- Analyst Count
- EXLS 6
- BIO 4
- Target Price
- EXLS $51.33
- BIO $333.50
- AVG Volume (30 Days)
- EXLS 1.5M
- BIO 221.8K
- Earning Date
- EXLS 10-28-2025
- BIO 10-29-2025
- Dividend Yield
- EXLS N/A
- BIO N/A
- EPS Growth
- EXLS 34.45
- BIO N/A
- EPS
- EXLS 1.45
- BIO 11.49
- Revenue
- EXLS $1,968,978,000.00
- BIO $2,554,200,000.00
- Revenue This Year
- EXLS $14.72
- BIO $2.12
- Revenue Next Year
- EXLS $11.47
- BIO $2.90
- P/E Ratio
- EXLS $29.68
- BIO $26.58
- Revenue Growth
- EXLS 15.15
- BIO N/A
- 52 Week Low
- EXLS $38.26
- BIO $211.43
- 52 Week High
- EXLS $52.43
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- EXLS 46.71
- BIO 65.02
- Support Level
- EXLS $43.17
- BIO $266.71
- Resistance Level
- EXLS $44.15
- BIO $286.84
- Average True Range (ATR)
- EXLS 0.82
- BIO 8.45
- MACD
- EXLS -0.00
- BIO 2.05
- Stochastic Oscillator
- EXLS 41.59
- BIO 99.44
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.